Vita Pure IV, a wellness clinic, and its partner company Clinical Research Partners have been conducting studies on popular weight loss medications such as Ozempic and Wegovvy. The clinic’s founder, Annette Bennett, emphasizes the importance of patient safety and ensuring only eligible patients receive these medications. For over a decade, these companies have been examining their effects on patients with cardiovascular issues and diabetes, prioritizing safe usage.
Bennett and the clinic’s Medical Director, Dr. Kara Foster-Weiss, express concern about people seeking quick weight loss solutions and ordering medications like Ozempic or its generic alternative semaglutide online, due to doubts around the safety of these products. According to Dr. Foster-Weiss, the ideal candidate for these medications should be motivated to make personal effort for their weight loss.
Jessica Bond, a mother of four, shared her experience of struggling with an endocrine disorder that prevented her from losing weight despite various diet plans and workouts. Over 18 months, she successfully lost 85 pounds with the help of a diabetes medication named tirzepatide. However, she highlights that such medications alone cannot be a solution, they can only serve as a tool for wellness when coupled with lifestyle changes.
Bond, who is an organ transplant coordinator, underlines the prevalence of chronic obesity she sees every day, which often disqualifies potential organ donors. She identifies obesity as one of America’s main health issues and believes in fighting the battle against it. Along with her weight, her other health problems like neuropathy, hair loss, psoriasis, and mood disorders also diminished.
At the same time, Bennett points out that Vita Pure IV has managed to avoid medication shortages by using a compounding pharmacy and that they continue to screen patients carefully to identify possible beneficiaries. She reiterates the importance of extensive screening to ensure appropriate usage and to avoid possible complications such as pancreatitis.
Weight loss medications like Ozempic are typically prescribed to obese individuals with a BMI greater than 30, but they can also be administered to overweight people with other chronic conditions. It’s recommended that patients should have in-depth discussions with their doctors and be ready to adopt necessary lifestyle modifications for successful long-term weight loss. Conclusive success is dependent on a combination of factors including medications, dietary changes, and consistent exercise.
